Corpus Intelligence IC Memo — UPMC JAMESON 2026-04-26 12:05 UTC
IC Memo — UPMC JAMESON
Investment Committee Memorandum | PA | 134 beds | Grade C | EBITDA uplift $8.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

UPMC JAMESON

CCN 390016 | nan, PA | 134 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

UPMC JAMESON is a 134-bed under-performing / distressed in nan, PA with $115.1M in net patient revenue and a -30.0% operating margin. The hospital serves a payer mix of 21.7% Medicare, 1.0% Medicaid, and 77.2% commercial.

Thesis: Undervalued. Our ML models identify $8.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -30.0% to -22.6% (+736bps).

Net Revenue HCRIS$115.1M
Current EBITDA COMPUTED$-34.5M
Operating Margin COMPUTED-30.0%
Occupancy HCRIS56.0%
Revenue / Bed COMPUTED$859K
Net-to-Gross HCRIS23.9%
Distress Probability ML45.7%

2. Market Context & Competitive Position

225
PA Hospitals
-4.4%
State Median Margin
107
Comparable Hospitals

PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of -30.0% places it below the state median. Among 107 size-comparable peers (67-268 beds), the median margin is -6.2%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (67-268), prioritizing same-state peers. 107 hospitals in the comp set.

HospitalStateBedsRevenueMargin
UPMC JAMESON (Target)PA134$115.1M-30.0%
WESTERN PENNSYLVANIA HOSPITALPA255$776.4M11.1%
COMMUNITY MEDICAL CENTERPA266$474.1M3.1%
ROBERT PACKER HOSPITALPA252$471.8M-2.1%
WILLIAMSPORT HOSPITAL & MEDICAPA227$459.8M-8.4%
MOUNT NITTANY MEDICAL CENTERPA248$441.7M12.6%
MEMORIAL MEDICAL CENTERPA241$435.1M-21.2%
THE CHAMBERSBURG HOSPITALPA234$435.1M5.2%
ST LUKE HOSPITAL ANDERSON CAMPPA193$433.0M20.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $8.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.4M+210bp18mo
Cost to Collect4.5%2.5%$2.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.4M+122bp9mo
Clean Claim Rate88.0%96.0%$74K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.4M
Cost to Collect
$2.3M
Denial Rate Reduction
$2.3M
A/R Days Reduction
$1.4M
Clean Claim Rate
$74K
Total EBITDA Uplift$8.5M
Current EBITDA$-34.5M
+ RCM Uplift+$8.5M
Pro Forma EBITDA$-26.0M
Current Margin-30.0%
Pro Forma Margin-22.6%
WC Released (1x)$4.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-53.0M$-142.7M0.00x-100.0%
Base (11x exit)10.0x11.0x$-53.0M$-174.2M0.00x-100.0%
Bull Case9.0x11.0x$-47.7M$-163.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-47.7M$-192.5M0.00x-100.0%
Bear Case11.0x10.0x$-58.4M$-167.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-58.4M$-203.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 107 hospitals with 67-268 beds
  • Same-state prioritization (n=108)
  • Comp margins: P25=-18.1% / P50=-6.2% / P75=5.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.